Victoria E Brings Selected Research

naphthalen- 1- yl- (4- pentyloxynaphthalen- 1- yl)methanone

1/2022

The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of central nervous system activity with repeated dosing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria E Brings Research Topics

Disease

1	Hyperalgesia 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pain (Aches) 01/2022
1	Melanoma (Melanoma, Malignant) 10/2014
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2014

Drug/Important Bio-Agent (IBA)

1	naphthalen- 1- yl- (4- pentyloxynaphthalen- 1- yl)methanoneIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2014
1	Diacylglycerol KinaseIBA 05/2014

Therapy/Procedure

1	Analgesia 01/2022